Arnout van Hyfte

Arnout Van Hyfte currently serves as the VP of Platform & Growth at MindWalk Corp., previously known as ImmunoPrecise Antibodies, starting in August 2025. Prior to this role, Arnout held significant positions at BioStrand, a subsidiary of IPA, from 2017 until September 2025, including Head of Product & Platform and Chief Commercial Officer. In the role of Chief Commercial Officer, Arnout was responsible for implementing growth initiatives to ensure profitability in the first year, defining the company's technical solutions, establishing an inbound sales and marketing strategy, and automating sales processes following product launches. As a member of the founding team at BioStrand, Arnout contributed to securing external funding of 2 million, co-authoring several pending patents, and establishing the business framework alongside product development efforts.